Cargando…
Venous Thromboembolism and Thymic Hyperplasia in the Setting of Silent Graves' Disease
Venous thromboembolism is a common, yet serious life-threatening condition that has many well-recognized associations which include but are not limited to pregnancy, polycythemia, trauma, immobility, and malignancy. The pathophysiology behind the pro-coagulant effects of hyperthyroidism has been wel...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9085705/ https://www.ncbi.nlm.nih.gov/pubmed/35547433 http://dx.doi.org/10.7759/cureus.23935 |
_version_ | 1784703876852613120 |
---|---|
author | Rayan, Melanie N Jones, Tyler S Ruiz de Villa, Ariel Calestino, Matthew Bazikian, Yvette |
author_facet | Rayan, Melanie N Jones, Tyler S Ruiz de Villa, Ariel Calestino, Matthew Bazikian, Yvette |
author_sort | Rayan, Melanie N |
collection | PubMed |
description | Venous thromboembolism is a common, yet serious life-threatening condition that has many well-recognized associations which include but are not limited to pregnancy, polycythemia, trauma, immobility, and malignancy. The pathophysiology behind the pro-coagulant effects of hyperthyroidism has been well established; however, there are no current guidelines regarding deep venous thrombosis (DVT) surveillance in patients with hyperthyroidism. In this report, we discuss the case of a 36-year-old female with no significant past medical history (PMH) with the exception of a 15 pack-year smoking history, who presented to us with an extensive, rapidly-progressing lower extremity DVT. Despite aggressive treatment measures, she developed a pulmonary embolus in the hospital. During her stay, she was diagnosed with Graves’ disease by hormone profile and thyroid-stimulating hormone receptor (TSH-R) antibody positivity. Additionally, an incidental thymic mass, likely thymic hyperplasia, was found on imaging and presumed to be associated with Graves’ disease. This case study reports a difficult-to-treat venous thromboembolism in the setting of Graves’ disease along with a review of current literature and pathophysiology on the subject. |
format | Online Article Text |
id | pubmed-9085705 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Cureus |
record_format | MEDLINE/PubMed |
spelling | pubmed-90857052022-05-10 Venous Thromboembolism and Thymic Hyperplasia in the Setting of Silent Graves' Disease Rayan, Melanie N Jones, Tyler S Ruiz de Villa, Ariel Calestino, Matthew Bazikian, Yvette Cureus Endocrinology/Diabetes/Metabolism Venous thromboembolism is a common, yet serious life-threatening condition that has many well-recognized associations which include but are not limited to pregnancy, polycythemia, trauma, immobility, and malignancy. The pathophysiology behind the pro-coagulant effects of hyperthyroidism has been well established; however, there are no current guidelines regarding deep venous thrombosis (DVT) surveillance in patients with hyperthyroidism. In this report, we discuss the case of a 36-year-old female with no significant past medical history (PMH) with the exception of a 15 pack-year smoking history, who presented to us with an extensive, rapidly-progressing lower extremity DVT. Despite aggressive treatment measures, she developed a pulmonary embolus in the hospital. During her stay, she was diagnosed with Graves’ disease by hormone profile and thyroid-stimulating hormone receptor (TSH-R) antibody positivity. Additionally, an incidental thymic mass, likely thymic hyperplasia, was found on imaging and presumed to be associated with Graves’ disease. This case study reports a difficult-to-treat venous thromboembolism in the setting of Graves’ disease along with a review of current literature and pathophysiology on the subject. Cureus 2022-04-07 /pmc/articles/PMC9085705/ /pubmed/35547433 http://dx.doi.org/10.7759/cureus.23935 Text en Copyright © 2022, Rayan et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Endocrinology/Diabetes/Metabolism Rayan, Melanie N Jones, Tyler S Ruiz de Villa, Ariel Calestino, Matthew Bazikian, Yvette Venous Thromboembolism and Thymic Hyperplasia in the Setting of Silent Graves' Disease |
title | Venous Thromboembolism and Thymic Hyperplasia in the Setting of Silent Graves' Disease |
title_full | Venous Thromboembolism and Thymic Hyperplasia in the Setting of Silent Graves' Disease |
title_fullStr | Venous Thromboembolism and Thymic Hyperplasia in the Setting of Silent Graves' Disease |
title_full_unstemmed | Venous Thromboembolism and Thymic Hyperplasia in the Setting of Silent Graves' Disease |
title_short | Venous Thromboembolism and Thymic Hyperplasia in the Setting of Silent Graves' Disease |
title_sort | venous thromboembolism and thymic hyperplasia in the setting of silent graves' disease |
topic | Endocrinology/Diabetes/Metabolism |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9085705/ https://www.ncbi.nlm.nih.gov/pubmed/35547433 http://dx.doi.org/10.7759/cureus.23935 |
work_keys_str_mv | AT rayanmelanien venousthromboembolismandthymichyperplasiainthesettingofsilentgravesdisease AT jonestylers venousthromboembolismandthymichyperplasiainthesettingofsilentgravesdisease AT ruizdevillaariel venousthromboembolismandthymichyperplasiainthesettingofsilentgravesdisease AT calestinomatthew venousthromboembolismandthymichyperplasiainthesettingofsilentgravesdisease AT bazikianyvette venousthromboembolismandthymichyperplasiainthesettingofsilentgravesdisease |